Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer, & Others), By Region, And Segment Forecasts, 2024 - 2030

Breast Lesion Localization Methods Market Size, Share & Trends Analysis Report By Type (Wire Guided Localization, Radioisotope Localization, Magnetic Tracer, & Others), By Region, And Segment Forecasts, 2024 - 2030


Breast Lesion Localization Methods Market Growth & Trends

The global breast lesion localization methods market size is anticipated to reach USD 3.62 billion by 2030 and is anticipated to grow at a CAGR of 7.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing government and non-government reimbursement policies for breast cancer diagnostics, biopsies, examinations, and related medical procedures are projected to drive adoption of breast lesion localization methods. Furthermore, the growing demand for improved healthcare infrastructure and facilities, driven by the rising prevalence of the disease among women, is anticipated to boost the market growth.

As the incidence of breast cancer among women rises, there is a heightened need for precise and early detection methods. Breast lesion localization techniques are pivotal in accurately identifying and targeting suspicious lesions for biopsy or surgical intervention. For instance, As per a report by National Breast Cancer Foundation, Inc., in April 2024, approximately 1 out of every 8 women in the U.S. will receive a breast cancer diagnosis during her lifetime. In 2024, it is projected that around 310,720 women and 2,800 men will be diagnosed with invasive breast cancer. With the increasing prevalence of breast cancer, there is a growing focus on tailored treatment strategies. Advanced lesion localization methods empower oncologists and surgeons to meticulously plan and deliver treatments, aiming for the best possible patient outcomes. These factors are driving the demand for breast lesions localizations methods.

Advancements in imaging technologies like digital mammography, ultrasound, and MRI have greatly improved the detection and characterization of breast lesions. As a result, there is an increased need for precise localization techniques to guide surgical procedures accurately. Furthermore, the integration of 3D imaging modalities and navigation systems allows surgeons to visualize breast lesion locations in real-time during procedures, significantly enhancing surgical precision and improving patient outcomes. These factors are propelling the market growth over the forecast period.

Breast Lesion Localization Methods Market Report Highlights
  • Based on type, the wire-guided localization segment held the largest market share in 2023 owing to the presence of a wide range of products and high adoption of this technique among end-users.
  • Radioisotope localization is expected to witness significant growth over the forecast period as it is an effective, safe, and widely used procedure for preoperative localization of non-palpable, suspicious breast lesions.
  • North America dominated the market with the highest revenue share in 2023 owing to the presence of key manufacturers in the region, established healthcare infrastructure, and high adoption of localization devices.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Breast Lesion Localization Methods Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising prevalence of breast cancer among women
3.2.1.2. Increasing awareness through cancer screening programs
3.2.1.3. Technological advancements
3.2.1.4. Availability of various techniques
3.2.1.5. Demand for minimally invasive and accurate procedures
3.2.2. Market Restraints Analysis
3.2.2.1. Risk associated with breast localization methods
3.2.2.2. Presence of complicated regulatory framework
3.3. Breast Lesion Localization Methods Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Breast Lesion Localization Methods Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Breast Lesion Localization Methods Market: Type Movement Analysis, USD Million, Volume Unit, 2023 & 2030
4.3. Global Breast Lesion Localization Methods Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million, Volume Unit,)
4.4. Wire Guided Localization
4.4.1. Wire guided localization market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)
4.5. Radioisotope Localization
4.5.1. Radioisotope localization market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.2. Radio guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.2.1. Radio Guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.3. Radio guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.3.1. Radio Guided occult-lesion localization (ROLL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.4. Radioactive-seed localization (RSL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.4.1. Radioactive-seed localization (RSL) market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.5. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.5.5.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.6. Magnetic Tracer
4.6.1. Magnetic tracer market revenue estimates and forecasts, 2018 - 2030 (USD million)
4.7. Others
4.7.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD Million, Volume Unit)
Chapter 5. Breast Lesion Localization Methods Market: Regional Estimates & Trend Analysis by Type
5.1. Regional Dashboard
5.2. Market Size and Trend Analysis, 2018 to 2030
5.3. North America
5.3.1. North America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.2. U.S.
5.3.2.1. Key country dynamics
5.3.2.2. Competitive scenario
5.3.2.3. Regulatory framework
5.3.2.4. Reimbursement scenario
5.3.2.5. U.S. breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.3. Canada
5.3.3.1. Key country dynamics
5.3.3.2. Competitive scenario
5.3.3.3. Regulatory framework
5.3.3.4. Reimbursement scenario
5.3.3.5. Canada breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.3.4. Mexico
5.3.4.1. Key country dynamics
5.3.4.2. Competitive scenario
5.3.4.3. Regulatory framework
5.3.4.4. Reimbursement scenario
5.3.4.5. Mexico breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4. Europe
5.4.1. Europe breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. UK
5.4.2.1. Key country dynamics
5.4.2.2. Competitive scenario
5.4.2.3. Regulatory framework
5.4.2.4. Reimbursement scenario
5.4.2.5. UK breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.3. Germany
5.4.3.1. Key country dynamics
5.4.3.2. Competitive scenario
5.4.3.3. Regulatory framework
5.4.3.4. Reimbursement scenario
5.4.3.5. Germany breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.4. France
5.4.4.1. Key country dynamics
5.4.4.2. Competitive scenario
5.4.4.3. Regulatory framework
5.4.4.4. Reimbursement scenario
5.4.4.5. France breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.5. Italy
5.4.5.1. Key country dynamics
5.4.5.2. Competitive scenario
5.4.5.3. Regulatory framework
5.4.5.4. Reimbursement scenario
5.4.5.5. Italy breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.6. Spain
5.4.6.1. Key country dynamics
5.4.6.2. Competitive scenario
5.4.6.3. Regulatory framework
5.4.6.4. Reimbursement scenario
5.4.6.5. Spain breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.7. Sweden
5.4.7.1. Key country dynamics
5.4.7.2. Competitive scenario
5.4.7.3. Regulatory framework
5.4.7.4. Reimbursement scenario
5.4.7.5. Sweden breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.8. Denmark
5.4.8.1. Key country dynamics
5.4.8.2. Competitive scenario
5.4.8.3. Regulatory framework
5.4.8.4. Reimbursement scenario
5.4.8.5. Denmark breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.9. Norway
5.4.9.1. Key country dynamics
5.4.9.2. Competitive scenario
5.4.9.3. Regulatory framework
5.4.9.4. Reimbursement scenario
5.4.9.5. Norway breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Asia Pacific breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Competitive scenario
5.5.2.3. Regulatory framework
5.5.2.4. Reimbursement scenario
5.5.2.5. China breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Japan
5.5.3.1. Key country dynamics
5.5.3.2. Competitive scenario
5.5.3.3. Regulatory framework
5.5.3.4. Reimbursement scenario
5.5.3.5. Japan breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.4. India
5.5.4.1. Key country dynamics
5.5.4.2. Competitive scenario
5.5.4.3. Regulatory framework
5.5.4.4. Reimbursement scenario
5.5.4.5. India breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.5. South Korea
5.5.5.1. Key country dynamics
5.5.5.2. Competitive scenario
5.5.5.3. Regulatory framework
5.5.5.4. Reimbursement scenario
5.5.5.5. South Korea breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.6. Australia
5.5.6.1. Key country dynamics
5.5.6.2. Competitive scenario
5.5.6.3. Regulatory framework
5.5.6.4. Reimbursement scenario
5.5.6.5. Australia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.7. Thailand
5.5.7.1. Key country dynamics
5.5.7.2. Competitive scenario
5.5.7.3. Regulatory framework
5.5.7.4. Reimbursement scenario
5.5.7.5. Thailand breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Latin America
5.6.1. Latin America breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.2. Brazil
5.6.2.1. Key country dynamics
5.6.2.2. Competitive scenario
5.6.2.3. Regulatory framework
5.6.2.4. Reimbursement scenario
5.6.2.5. Brazil breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3. Argentina
5.6.3.1. Key country dynamics
5.6.3.2. Competitive scenario
5.6.3.3. Regulatory framework
5.6.3.4. Reimbursement scenario
5.6.3.5. Argentina breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Middle East and Africa
5.7.1. Middle East and Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.2. South Africa
5.7.2.1. Key country dynamics
5.7.2.2. Competitive scenario
5.7.2.3. Regulatory framework
5.7.2.4. Reimbursement scenario
5.7.2.5. South Africa breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.3. Saudi Arabia
5.7.3.1. Key country dynamics
5.7.3.2. Competitive scenario
5.7.3.3. Regulatory framework
5.7.3.4. Reimbursement scenario
5.7.3.5. Saudi Arabia breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.4. UAE
5.7.4.1. Key country dynamics
5.7.4.2. Competitive scenario
5.7.4.3. Regulatory framework
5.7.4.4. Reimbursement scenario
5.7.4.5. UAE breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.5. Kuwait
5.7.5.1. Key country dynamics
5.7.5.2. Competitive scenario
5.7.5.3. Regulatory framework
5.7.5.4. Reimbursement scenario
5.7.5.5. Kuwait breast lesion localization methods market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Market Share Analysis, 2023
6.4. Company Heat Map Analysis
6.5. Strategy Mapping
6.5.1. Expansion
6.5.2. Mergers & Acquisition
6.5.3. Partnerships & Collaborations
6.5.4. New Product Launches
6.5.5. Research And Development
6.5.6. Company Profiles
6.5.7. BD
6.5.7.1. Company overview
6.5.7.2. Financial performance
6.5.7.3. Product Benchmarking
6.5.7.4. Strategic initiatives
6.5.8. SOMATEX Medical Technologies GmbH
6.5.8.1. Company overview
6.5.8.2. Financial performance
6.5.8.3. Product Benchmarking
6.5.8.4. Strategic initiatives
6.5.9. Argon Medical Devices
6.5.9.1. Company overview
6.5.9.2. Financial performance
6.5.9.3. Product Benchmarking
6.5.9.4. Strategic initiatives
6.5.10. Merit Medical Systems
6.5.10.1. Company overview
6.5.10.2. Financial performance
6.5.10.3. Product Benchmarking
6.5.10.4. Strategic initiatives
6.5.11. Cook Medical
6.5.11.1. Company overview
6.5.11.2. Financial performance
6.5.11.3. Product Benchmarking
6.5.11.4. Strategic initiatives
6.5.12. STERYLAB S.r.l.
6.5.12.1. Company overview
6.5.12.2. Financial performance
6.5.12.3. Product Benchmarking
6.5.12.4. Strategic initiatives
6.5.13. Theragenics Corporation
6.5.13.1. Company overview
6.5.13.2. Financial performance
6.5.13.3. Product Benchmarking
6.5.13.4. Strategic initiatives
6.5.14. MDL SRL
6.5.14.1. Company overview
6.5.14.2. Financial performance
6.5.14.3. Product Benchmarking
6.5.14.4. Strategic initiatives
6.5.15. MOLLI Surgical
6.5.15.1. Company overview
6.5.15.2. Financial performance
6.5.15.3. Product Benchmarking
6.5.15.4. Strategic initiatives
6.5.16. Mermaid Medical
6.5.16.1. Company overview
6.5.16.2. Financial performance
6.5.16.3. Product Benchmarking
6.5.16.4. Strategic initiatives
6.5.17. IsoAid
6.5.17.1. Company overview
6.5.17.2. Financial performance
6.5.17.3. Product Benchmarking
6.5.17.4. Strategic initiatives
6.5.18. Intramedical Imaging, LLC
6.5.18.1. Company overview
6.5.18.2. Financial performance
6.5.18.3. Product Benchmarking
6.5.18.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings